HealthParkinson's disease progression slowed by antibody infusions Monthly infusions with the drug prasinezumab appeared to slow the progression of motor symptoms in people with advanced Parkinson's disease News
Health2023 saw a cautious hope for Alzheimer's treatment but doubts remain The US approved lecanemab to slow cognitive decline among people with early Alzheimer's, but not everyone is convinced the drug has that big of an impact – not to mention concerns over its safety and practicality News